GGrantIndex
Sort

130,381 grants matching hiv

Florida Node Alliance of the Drug Abuse Clinic Trials Network

$1,066,340
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2014 · DA

CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) EXTENSION

$1,066,335
Igor Grant · California Univ San Diego · N01 · FY2014 · MH

International HIV ARV Adherence, Resistance and Survival

$1,066,318
David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2008 · MH

Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens

$1,066,201
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI

HIV-1 Therapy with CCR5 mAB PRO 140-Overview

$1,066,099
Progenics Pharmaceuticals, Inc. · U19 · FY2005 · AI

A ProgramPharmacy Chains to Increase PrEP Awareness and Access Among Men

$1,066,077
Mariano Juan Kanamori Nishimura · University Of Miami School Of Medicine · R01 · FY2025 · AI

ALCOHOL, HIV, AND THE BRAIN

$1,065,828
Sri International · R01 · FY2002 · AA

Understanding and Preventing Childhood Drug Use Risk

$1,065,526
Thomas J Dishion · University Of Oregon · R01 · FY2011 · DA

A Novel Technology to Improve HIV Medication Compliance

$1,065,462
Vesta Brue · Lifetechniques, Inc. · R44 · FY2007 · AI

Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

$1,065,423
Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI

Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1

$1,065,397
Pamela J Bjorkman · California Institute Of Technology · P01 · FY2021 · AI

Functional genomic analysis of the CD8 T cell response to HIV vaccines in

$1,065,338
William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2011 · AI

High Risk Drug Use &HIV-Learning from the NYC Epidemic

$1,065,269
National Development &Res Institutes · P30 · FY2004 · DA

FEMALE GENITAL TRACT IN HIV PATHOGENESIS

$1,065,108
Rush University Medical Center · P01 · FY2001 · HD

Collaborative African Genomics Network (CAfGEN)

$1,065,022
Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2017 · AI

Texas Center for Minority Health, Education, Research and Outreach

$1,064,981
Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2018 · MD

Third Coast Center For AIDS Research

$1,064,754
Brian Mustanski · Northwestern University At Chicago · P30 · FY2023 · AI

Role of myeloid cells in CNS and systemic reservoirs and rebound

$1,064,451
Thomas Hope · Northwestern University At Chicago · R01 · FY2022 · MH

Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons

$1,064,438
Jeffrey H Samet · Boston Medical Center · R01 · FY2017 · DA

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

$1,064,245
Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2025 · CA

Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60

$1,064,206
Victor Valcour · University Of California, San Francisco · R01 · FY2017 · MH

Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse

$1,064,093
Stuart A Lipton · Scripps Research Institute, The · DP1 · FY2019 · DA

Center for Targeted Therapeutics 2

$1,063,913
Hippokratis Kiaris · University Of South Carolina At Columbia · P20 · FY2023 · GM

Papillomavirus Virion Proteins and Vaccines

$1,063,732
Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Appalachian Tri-State Node

$1,063,695
Dennis C Daley · University Of Pittsburgh At Pittsburgh · U10 · FY2012 · DA